Some hospitals not prepared for potential Ebola patients

Article

As healthcare workers in West Africa battle against Ebola, some experts in the United States question whether American hospitals would be able to protect their employees and the public should the disease.

As healthcare workers in West Africa battle against Ebola, some experts in the United States question whether American hospitals would be able to protect their employees and the public should the disease spread. 

Report: U.S. health care costs significantly higher than other countries

Under the watchful eye of the Centers for Disease Control and Prevention (CDC), Emory University Hospital in Atlanta is treating two American missionaries who were infected with the disease while in Liberia.

According to the CDC, symptoms of the disease include fever, headache, joint and muscle aches, weakness, diarrhea, vomiting, stomach pain, lack of appetite, and abnormal bleeding. Symptoms may appear anywhere from two to 21 days after exposure to ebolavirus. Ebola can be transmitted only through direct contact with blood or bodily fluids of a symptomatic person or through exposure to objects, such as needles, that have been contaminated.

A recent Fox News opinion piece noted that the danger comes from someone who is unknowingly infected with Ebola travels to the United States and goes to an emergency room after he becomes symptomatic.

“Many hospitals are poorly prepared to contain any pathogen. That’s why at least 75,000 people a year die from hospital infections,” writes Betsy McCaughey, PhD, former Lt. Governor of New York. 

“Whether Americans die of Ebola will depend largely on what hospitals do when the first victims unknowingly carrying the virus are admitted,” says Dr. McCaughey.

The CDC recently issued a notice reminding U.S. healthcare workers of the importance of taking steps to prevent the spread of this virus, how to test and

“The CDC also needs to improve its own infection control rigor. In the last three months, three incidents of the CDC mishandling pathogens-anthrax, avian flu, and smallpox-have come to light. Why assume the agency’s ready for Ebola?” writes Dr. McCaughey.

Formulary News: WHO okays experimental drug use in Ebola outbreak

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Shelby Brogdon, OD, details opportunities for practices to answer the patient's concerns from the chair before they hit the internet for their contact lens needs.
Christi Closson, OD, FAAO, shares her excitement for the new Acuvue Oasys MAX 1-Day multifocal for astigmatism
Karen R. Hoffman, OD, shares how customizable scleral lenses can transform vision for patients with complex corneas, achieving 20/20 outcomes and enhanced comfort.
Janna Pham, OD, shares key takeaways from a corneal tomography session she presented alongside Travis Pfeifer, OD, and Matthew McGee, OD.
Jacob Lang, OD, FAAO, details early symptom relief demonstrated in as early as day 1 during AOA's Optometry's Meeting 2025.
When Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, began fitting scleral lenses 20 years ago, there was limited knowledge about conjunctival characteristics, scleral shape, and lens behavior.
Ioussifova details what sets Johnson & Johnson's new lens apart from the rest, which was launched at the American Optometric Association's Optometry's Meeting 2025.
Alongside Rachel Steele, OD, Rafieetary outlines what to look for in blurred disc margins and the importance of acting fast and sending patients to the ED when needed.
Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, emphasized that every staff member should play a role in myopia management during his presentation at Optometry's Meeting 2025.
Dr Ashley Tucker Wallace discusses the intersection of pediatric dry eye and myopia control
© 2025 MJH Life Sciences

All rights reserved.